37
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T12943 |
SNDX-5613
|
Epigenetic Reader Domain; Histone Methyltransferase | Chromatin/Epigenetic |
SNDX-5613 是一种 Menin-MLL 特异性抑制剂,Ki 为 0.149 nM,IC50 为 10 在 20 nM 之间,可用于 MLL 基因重排的急性白血病研究。 | |||
T7955 |
EB-3D
|
Apoptosis; AMPK; AChR | Apoptosis; Chromatin/Epigenetic; Neuroscience; PI3K/Akt/mTOR signaling |
EB-3D 是一种选择性胆碱激酶 α 抑制剂,对 ChoKα1 的IC50值为 1 μM。它影响 ChoKα 表达、AMPK 激活、细胞凋亡、内质网应激和脂质代谢,具有抗癌活性。 | |||
T8003 |
Methotrexate disodium
|
Apoptosis; Dehydrogenase; DNA/RNA Synthesis; Antifolate | Apoptosis; Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Metabolism |
Methotrexate disodium 是一种叶酸类似物代谢抑制剂,具有免疫抑制剂和抗肿瘤特性,用于类风湿关节炎和研究多种癌症。 | |||
T8308 |
NL-1
|
Mitochondrial Metabolism; Autophagy | Autophagy; Metabolism |
NL-1 是一种mitoNEET 抑制剂,具有抗白血病作用。它抑制 REH 和 REH/Ara-C 细胞生长,IC50分别为 47.35 µM 和 56.26 µM。 | |||
T6603 |
Nelarabine
GW 506U78,Nelzarabine,奈拉滨,506U78 |
Apoptosis; Nucleoside Antimetabolite/Analog; DNA/RNA Synthesis | Apoptosis; Cell Cycle/Checkpoint; DNA Damage/DNA Repair |
Nelarabine (GW 506U78) 是一种嘌呤核苷酸类似物,为DNA 合成抑制剂,对肿瘤细胞的IC50为0.067-2.15 μM,可作用于T 细胞急性淋巴细胞白血病。 | |||
TP1115 |
L-Asparaginase
L-ASNase |
Others | Others |
L-Asparaginase (L-ASNase) 是催化 L-天冬酰胺转化的水解酶,从血浆中去除 L-天冬酰胺,导致 RNA 和 DNA 合成抑制,随后引起细胞凋亡。它用于急性淋巴细胞白血病的研究。 | |||
T0370 |
Pheniramine maleate
Daneral,Inhiston,Trimetose,马来酸非尼拉敏 |
5-HT Receptor; Histamine Receptor | GPCR/G Protein; Immunology/Inflammation; Neuroscience |
Pheniramine maleate (Trimetose) 是一种具有抗组胺和血管扩张特性的烷基胺衍生物,可与组胺 H1 受体结合,从而抑制磷脂酶 A2 和内皮源性松弛因子一氧化氮的产生。 | |||
T16545 |
Pivanex
Pivalyloxymethyl butyrate,AN-9 |
Apoptosis; HDAC; Bcr-Abl | Angiogenesis; Apoptosis; Chromatin/Epigenetic; Cytoskeletal Signaling; DNA Damage/DNA Repair; Tyrosine Kinase/Adaptors |
Pivanex (Pivalyloxymethyl butyrate) 是丁酸的一种衍生物,是具有口服活性的 HDAC 抑制剂。Pivanex 通过下调 bcr-abl 蛋白增强凋亡。Pivanex 显示出抗转移和抗血管生成的活性。 | |||
T1485 |
Methotrexate
NCI-C04671,WR19039,Amethopterin,甲氨蝶呤,CL14377 |
Apoptosis; Dehydrogenase; DNA/RNA Synthesis; Antifolate | Apoptosis; Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Metabolism |
Methotrexate (WR19039) 是一种叶酸类似物,一种二氢叶酸还原酶 DHFR 的抑制剂。Methotrexate 具有抗代谢、抗肿瘤和免疫抑制等活性,常用于类风湿关节炎和多种肿瘤的研究。 | |||
T1477 |
AICAR
NSC105823,AICA Riboside,Acadesine,阿卡地新,AICAR (Acadesine) |
Mitophagy; YAP; AMPK; Autophagy | Autophagy; Chromatin/Epigenetic; PI3K/Akt/mTOR signaling; Stem Cells |
AICAR (NSC105823) 是一种腺苷类似物,是一种 AMP 激活的蛋白激酶激活剂,可用于治疗急性淋巴细胞白血病和糖尿病。 | |||
T74710 |
YX-2-107
|
CDK | Cell Cycle/Checkpoint |
YX-2-107 是一种具有选择性和高效性的降解 CDK6 的 PROTAC ,IC50 值为 4.4 nM。YX-2-107 在体外对 RB 磷酸化和 FOXM1 表达有抑制作用,对大鼠体内 Ph+ ALL 的发展有抑制作用。YX-2-107 可用于预防和治疗 Ph 染色体阳性 (Ph+) 急性淋巴细胞白血病 (ALL)。 | |||
T72984 |
(Rac)-SHIN2
|
Others | Others |
(Rac)-SHIN2 是一种丝氨酸羟甲基转移酶 (SHMT) 抑制剂,可提高 NOTCH1 驱动的小鼠原代 T-ALL 在体内的存活率,可用于研究 T 细胞急性淋巴细胞白血病 (T-ALL)。 | |||
T76790 |
Inotuzumab
|
Others | Others |
Inotuzumab (Humanized Anti-CD22 Recombinant Antibody) 是人源化靶向 CD22 的 IgG4 抗体。Inotuzumab 是 Inotuzumab ozogamicin 的裸抗,可用于合成抗体-活性分子偶联物 (Inotuzumab ozogamicin)。Inotuzumab 可于研究急性淋巴细胞白血病和非霍奇金淋巴瘤。 | |||
T21302L |
UNC 569 hydrochloride
UNC 569 hydrochloride (1350547-65-7 Free base) |
TAM Receptor; TAM Receptor | Tyrosine Kinase/Adaptors |
UNC 569 hydrochloride 是一种可逆的 ATP 竞争性 Mer 抑制剂,IC50 为 2.9 nM,Ki 为 4.3 nM。 UNC 569 hydrochloride 抑制 Axl 和 Tyro3,IC50 分别为 37 nM 和 48 nM。 UNC 569 hydrochloride 可用于关于急性淋巴细胞白血病和非典型畸胎样/横纹肌样肿瘤的研究。 | |||
T36944 |
Ara-G
|
Nucleoside Antimetabolite/Analog | Cell Cycle/Checkpoint; DNA Damage/DNA Repair |
Ara-G 是一种脱氧鸟苷 (GdR) 类似物和核苷类似物,可被 T 淋巴谱系细胞迅速转化为其相应的阿拉伯糖基鸟嘌呤核苷酸三磷酸 (araGTP),从而抑制 DNA 合成和对 T 淋巴母细胞的选择性体外毒性细胞系以及来自 T 细胞急性淋巴细胞白血病 (ALL) 患者的新鲜分离的白血病细胞。 | |||
T20858 |
Metanilic acid
m-Anilinesulfonic acid,m-Sulfanilic acid |
||
Metanilic acid, an anti-cancer drug, is used to treat several malignancies including choriocarcinoma and pediatric acute lymphoblastic leukemia. | |||
T30688 | Calaspargase pegol | ||
Calaspargase pegol is used to treat acute lymphoblastic leukemia. | |||
T24189 |
J9
J-9,J 9 |
||
J9 is an inhibitor of Glucocorticoid resistance. J9 reverses Dexamethasone Resistance in T-cell Acute Lymphoblastic Leukemia. | |||
T21301 |
Lesinurad sodium
Lesinurad,RDEA 594,RDEA-594,RDEA594 |
||
UNC569, the first small-molecule MER inhibitor, inhibits Mer activation and downstream signaling through ERK1/2 and AKTwith. UNC569 shows efficacy against acute lymphoblastic leukemia in vitro and in vivo. | |||
T36575 |
HDAC3 Inhibitor
|
||
HDAC3 inhibitor is an allosteric inhibitor of histone deacetylase 3 (HDAC3; Ki = 0.16 nM). It is selective for HDAC3 over HDAC1 and HDAC2 (IC50s = 0.95, 11.81, and 95.45 nM, respectively, using recombinant HDACs). In addition, it is selective for acute myeloid, monocytic, and lymphoblastic leukemia cell lines (EC50s = 36.37, 76.64, and 151.7 nM, respectively) over chronic myeloid, acute promyelocytic, and acute lymphoblastic cells (EC50s = 2,160, >10,000, and >10,000 nM, respectively). | |||
T79377 |
NWP-0476
|
||
NWP-0476为针对BCL-2/BCL-xL的抑制剂,其结构已优化以提高对BCL-xL的选择性。该化合物适用于复发性T-急性淋巴细胞白血病(T-ALL)的相关研究。 | |||
T31672 |
Erythrofuranosyladenine
9-β-D-Erythrofuranosyladenine,ETA |
||
Erythrofuranosyladenine(9-beta-D-Erythrofuranosyladenine, ETA) is a nontoxic MTAP substrate. Erythrofuranosyladenine is an effective salvage agent for methylthioadenosine phosphorylase–selective therapy of T-cell acute lymphoblastic leukemia with L-alanos | |||
T78317 |
Blinatumomab
Anatumomab |
||
Blinatumomab(亦称Anatumomab)是针对B细胞表面CD19抗原的双特异性单克隆抗体,主要用于急性淋巴细胞白血病的研究。 | |||
T25000 |
Acetylaleuritolic acid
NSC 266221,NSC-266221,NSC266221 |
||
Acetylaleuritolic acid 是一种从小花加西亚叶中分离得到的一种五环三萜类化合物,植物代谢产物。它具有抗肿瘤特性,对P-388淋巴细胞白血病测试中显示出肿瘤抑制活性。 | |||
T4310L2 |
Prexasertib mesylate
LY-2606368,LY2606368,LY 2606368 |
||
Prexasertib is a potent and selective Chk1/Chk2 inhibitor. Prexasertib increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemia. LY2606368 causes replication catastrophe and antitumor effects through CHK1-d | |||
T76801 | Denintuzumab | ||
Denintuzumab (hBU 12) 是一种重组人源化抗 CD19单克隆抗体。Denintuzumab 可作为抗体偶联活性分子的抗体部分 (ADC antibody) 合成 ADC,Denintuzumab Mafodotin (SGN-CD19A)。Denintuzumab Mafodotin 可用于急性淋巴细胞白血病的研究。 | |||
T39799 |
S2157
S2157 |
||
S2157, a potent N-alkylated tranylcypromine (TCP) derivative lysine-specific demethylase 1 (LSD1) inhibitor, enhances H3K9 methylation and concurrently reduces H3K27 acetylation at super-enhancer sites. This compound triggers apoptosis in TCP-resistant T-cell acute lymphoblastic leukemia (T-ALL) cells by inhibiting NOTCH3 and TAL1 gene expression. Moreover, S2157 is capable of crossing the blood-brain barrier, effectively eliminating central nervous system (CNS) leukemia in mice models implanted... | |||
T76893 | Lusvertikimab | ||
Lusvertikimab (OSE-127) 是一种人源化IL7R 单克隆抗体。Lusvertikimab 不会被靶细胞内化并阻止 IL7R 异二聚化和随后的下游信号传导。Lusvertikimab 具有抗白血病功效,具有用于 B 细胞前体急性淋巴细胞白血病 (BCP-ALL) 研究的潜力。 | |||
T74538 | Galectin-3 antagonist 2 | Galectin | Immunology/Inflammation |
Galectin-3,作为β-半乳糖苷特异性的识别蛋白(凝集素),具备促进B细胞前体急性淋巴细胞白血病(BCP-ALL)细胞迁移及耐受药物治疗的功能。 | |||
T60361 | LSD1/2-IN-4 | ||
LSD1/2-IN-4 是一种 PCPA 衍生物,是 LSD1 和 LSD2 的抑制剂。LSD1/2-IN-4 对 LSD1 和 LSD2 具有抑制作用,其Ki 值分别为 0.11 μM 和 130 μM。LSD1/2-IN-4 可用于多种癌症的研究,如 T 细胞急性淋巴细胞白血病 (TALL) 。 | |||
T37068 |
NR-160
|
||
NR-160 is an inhibitor of histone deacetylase 6 (HDAC6; IC50= 0.03 μM).1It is selective for HDAC6 over HDAC1, -2, -3, -4, and -8 (IC50s = 5.18, 2.26, 8.48, 55.4, and 14.7 μM, respectively). NR-160 is cytotoxic against a panel of seven cancer cell lines (IC50s = 22.5-51.8 μM). It enhances cytotoxicity induced by bortezomib in HL-60 cells, as well as cytotoxicity induced by epirubicin or daunorubicin in CCRF-HSB-2 T cell acute lymphoblastic leukemia cells. | |||
T39800 |
S2116
|
||
S2116 is a powerful inhibitor of lysine-specific demethylase 1 (LSD1), and it is a derivative of N-alkylated tranylcypromine (TCP). S2116 exhibits its inhibitory effects by increasing H3K9 methylation and inducing reciprocal H3K27 deacetylation at super-enhancer regions. In TCP-resistant T-cell acute lymphoblastic leukemia (T-ALL) cells, S2116 triggers apoptosis by repressing the transcription of NOTCH3 and TAL1 genes. Furthermore, S2116 demonstrates significant growth retardation of T-ALL cells... | |||
T35810 |
C24 dihydro Ceramide (d18:0/24:0)
Cer(d18:0/24:0) |
||
C24 dihydro Ceramide is a sphingolipid that has been found in the stratum corneum of human skin.[1] It is found in higher concentrations in female sebum compared to male sebum.[2] C24 dihydro Ceramide levels positively correlate with cytotoxicity in CCRF-CEM, MOLT-4, COG-LL-317h, and COG-LL-332h T cell acute lymphoblastic leukemia (ALL) cell lines.[4] Levels of C24 dihydro ceramide are increased by 149.49-fold in dihydroceramide desaturase 1 (DEGS1) knockdown UM-SCC-22A human head and neck squam... | |||
T74994 | SJ988497 | ||
SJ988497是一种PROTACJAK2降解剂,有效地抑制CRLF2重排(CRLF2r)细胞增殖并降解CRBN新底物GSPT1。该化合物由Ruxolitinib衍生物、连接子以及CRBN配体Pomalidomide构成,可作为急性淋巴细胞白血病(ALL)研究用途。 | |||
T79012 | MDM2/XIAP-IN-2 | ||
MDM2/XIAP-IN-2为MDM2(murine double minute 2)和XIAP(x-linked inhibitor of apoptosis protein)的双重抑制剂, 能够降解MDM2并抑制XIAP mRNA的翻译,进而抑制癌细胞生长。该化合物在针对急性淋巴细胞白血病细胞系EU-1的研究中显示出优秀的抑制效果,IC50值为0.3 μM。 | |||
T82259 |
Grisnilimab setaritox
WT1-RTA |
||
Grisnilimab setaritox (WT1-RTA) 是抗人 T 细胞抗体 (anti-CD7) 与蓖麻毒素 A 链 (RTA) 的结合物。RTA 是一种质量为 30 kda 的肽,能迅速活化 60S 核糖体亚基。Grisnilimab setaritox 对体外 CEM (T 淋巴母细胞白血病) 细胞具有显著细胞毒性,ID50 为 53 pM,并在恒河猴白血病性脑膜炎模型中显示出疗效改善。 | |||
T83930 |
SJ 11646
|
||
SJ11646是一种高效的LCK(淋巴细胞特异性蛋白酪氨酸激酶)降解剂(PROTAC;DC50= 0.00838 pM)。该化合物由Dasatinib作为LCK配体,以及基于苯基谷氨酰亚胺的cereblon结合体组成。它在体外对LCK激活的T细胞急性淋巴细胞白血病(T-ALL)细胞株和初级白血病样本展现出细胞毒性。在体内,SJ11646在源自患者的T-ALL异种移植模型中显示出抗白血病效果。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN4311 |
Isomitraphylline
|
Others | Others |
Isomitraphylline and pteropodine are the most suitable for standardization of medical cat's claw preparations. Isomitraphylline can inhibit proliferation of acute lymphoblastic leukaemia cells. |